Literature DB >> 20803334

A comparison of novel light sources for photodynamic therapy.

M L De Jode1, J A McGilligan, M G Dilkes, I Cameron, P B Hart, M F Grahn.   

Abstract

A diode laser, light-emitting diode (LED) array bandwidth 25 nm, full width half maximum (FWHM) and filtered arc lamp (bandwidth 40 nm, FWHM), all with peak emission at about 650 nm, suitable for the photosensitizer tetra(meta-hydroxyphenyl)chlorin (mTHPC), were compared with a copper vapour laser pumped dye laser, using depth of necrosis in normal rat liver as a measure of photodynamic effect.A three-way comparison between a DL10K dye laser, the LED array and the filtered arc lamp resulted in mean depths of necrosis of 4.64, 4.29 and 4.04 mm, respectively, at 20 J cm(-2), the values for the laser and arc lamp being significantly different at the 5% level. A further comparison of a narrower linewidth DL20K dye laser with the LED array, using a light dose of 20 J cm(-2), showed a significant difference between the mean depths of necrosis of 4.97 and 4.05 mm, respectively (p=0.01).A final study, comparing the DL20K dye laser with the diode laser and a light dose of 10 J cm(-2), demonstrated no significant difference in depths of necrosis (3.23 and 3.25 mm, respectively). The results obtained in the three studies are attributed to the relative bandwidths of light emission for the various sources. A simple mathematical model is presented explaining the results in terms of the relative activation of the photosensitizer and the consequent threshold fluence required for the induction of necrosis.It is concluded that, in order to achieve the same depth of effect as a laser when using the broad band sources, the incident fluence would have to be approximately doubled. However, when the low cost and ease of use of the non-laser sources are taken into consideration, these devices are likely to find widespread applications in clinical photodynamic therapy.

Entities:  

Year:  1997        PMID: 20803334     DOI: 10.1007/BF02765107

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  9 in total

1.  In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine.

Authors:  M S Patterson; B C Wilson; R Graff
Journal:  Photochem Photobiol       Date:  1990-03       Impact factor: 3.421

2.  Comparison of the efficacy of pulsed and continuous-wave red laser light in induction of photocytotoxicity by haematoporphyrin derivative.

Authors:  P A Cowled; J R Grace; I J Forbes
Journal:  Photochem Photobiol       Date:  1984-01       Impact factor: 3.421

3.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

Authors:  J C Kennedy; R H Pottier; D C Pross
Journal:  J Photochem Photobiol B       Date:  1990-06       Impact factor: 6.252

4.  Photodynamic therapy for malignant tumours of the ampulla of Vater.

Authors:  A M Abulafi; J T Allardice; N S Williams; N van Someren; C P Swain; C Ainley
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

5.  Treatment of head and neck cancer with photodynamic therapy: results after one year.

Authors:  M G Dilkes; M L DeJode; Q Gardiner; G S Kenyon; P McKelvie
Journal:  J Laryngol Otol       Date:  1995-11       Impact factor: 1.469

6.  Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers.

Authors:  R Bonnett; R D White; U J Winfield; M C Berenbaum
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

7.  Light dosimetry model for photodynamic therapy treatment planning.

Authors:  L I Grossweiner
Journal:  Lasers Surg Med       Date:  1991       Impact factor: 4.025

8.  meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity.

Authors:  M C Berenbaum; S L Akande; R Bonnett; H Kaur; S Ioannou; R D White; U J Winfield
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

9.  Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver.

Authors:  S G Bown; C J Tralau; P D Smith; D Akdemir; T J Wieman
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

  9 in total
  3 in total

1.  C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres.

Authors:  Junseong Park; Seung Jae Oh; Jin-Kyoung Shim; Young Bin Ji; Ju Hyung Moon; Eui Hyun Kim; Yong-Min Huh; Jin-Suck Suh; Jong Hee Chang; Su-Jae Lee; Seok-Gu Kang
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-15       Impact factor: 4.322

2.  High-power light-emitting diode array design and assembly for practical photodynamic therapy research.

Authors:  Eric M Kercher; Kai Zhang; Matt Waguespack; Ryan T Lang; Alejandro Olmos; Bryan Q Spring
Journal:  J Biomed Opt       Date:  2020-04       Impact factor: 3.170

Review 3.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.